SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-021995
Filing Date
2023-05-15
Accepted
2023-05-15 09:01:14
Documents
54
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tern-20230331.htm   iXBRL 10-Q 1977976
2 EX-31.1 tern-ex31_1.htm EX-31.1 20052
3 EX-31.2 tern-ex31_2.htm EX-31.2 20053
4 EX-32.1 tern-ex32_1.htm EX-32.1 12045
5 EX-32.2 tern-ex32_2.htm EX-32.2 12052
  Complete submission text file 0000950170-23-021995.txt   9151886

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tern-20230331_pre.xml EX-101.PRE 395274
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tern-20230331_cal.xml EX-101.CAL 45041
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tern-20230331_lab.xml EX-101.LAB 530574
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tern-20230331.xsd EX-101.SCH 64443
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tern-20230331_def.xml EX-101.DEF 243334
48 EXTRACTED XBRL INSTANCE DOCUMENT tern-20230331_htm.xml XML 2069574
Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Filer) CIK: 0001831363 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39926 | Film No.: 23918811
SIC: 2834 Pharmaceutical Preparations